AstraZeneca US Trial Data a Confidence Booster for COVID-19 Shot
1 sourceUpdated Mar 22, 2021
AstraZeneca’s COVID-19 vaccine performed better than expected in a major late-stage trial, potentially paving the way for its emergency authorization in the United States and bolstering confidence in the shot after…
Claim check
What each side asserts, disputes — or leaves out entirely.
Where do you land?
Whose framing of this story rings truest to you?
Coverage
Comments
Ask this story anything:
Free account · your comment posts right after signup